Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
Status:
Recruiting
Trial end date:
2021-10-13
Target enrollment:
Participant gender:
Summary
The objective of the trial is to evaluate the efficacy of dasiglucagon in reducing glucose
requirements in children with persistent congenital hyperinsulinism (CHI) requiring
continuous intravenous (IV) glucose administration to prevent/manage hypoglycemia.